ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 724 filers reported holding ASTRAZENECA PLC in Q3 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $178,479,257 | -17.4% | 2,288,489 | -28.2% | 0.41% | -19.7% |
Q1 2024 | $216,078,801 | +36.3% | 3,189,355 | +35.5% | 0.51% | +39.3% |
Q4 2023 | $158,576,653 | +88.0% | 2,354,516 | +89.1% | 0.36% | +60.4% |
Q3 2023 | $84,336,592 | +1132.3% | 1,245,372 | +1202.4% | 0.23% | +1235.3% |
Q2 2023 | $6,843,810 | +276.6% | 95,624 | +265.3% | 0.02% | +240.0% |
Q1 2023 | $1,817,084 | -98.4% | 26,179 | -98.4% | 0.01% | -98.6% |
Q4 2022 | $112,118,419 | +158.9% | 1,653,664 | +109.4% | 0.35% | +139.5% |
Q3 2022 | $43,314,000 | +444.1% | 789,823 | +555.6% | 0.15% | +465.4% |
Q2 2022 | $7,960,000 | -67.0% | 120,478 | -66.9% | 0.03% | -63.4% |
Q1 2022 | $24,142,000 | -52.9% | 363,911 | -58.7% | 0.07% | -35.5% |
Q4 2021 | $51,289,000 | +182.1% | 880,505 | +190.8% | 0.11% | +168.3% |
Q3 2021 | $18,183,000 | -62.3% | 302,749 | -62.4% | 0.04% | -62.4% |
Q2 2021 | $48,206,000 | +1105.5% | 804,772 | +900.7% | 0.11% | +990.0% |
Q1 2021 | $3,999,000 | -86.8% | 80,424 | -86.0% | 0.01% | -93.3% |
Q2 2020 | $30,345,000 | +644.7% | 573,741 | +528.7% | 0.15% | +354.5% |
Q1 2020 | $4,075,000 | +4.5% | 91,253 | +16.7% | 0.03% | +175.0% |
Q4 2019 | $3,899,000 | -85.7% | 78,204 | -88.2% | 0.01% | -86.8% |
Q2 2019 | $27,331,000 | +12156.1% | 662,093 | +11672.6% | 0.09% | +9000.0% |
Q3 2018 | $223,000 | -95.0% | 5,624 | -95.6% | 0.00% | -92.3% |
Q2 2018 | $4,464,000 | -91.4% | 127,151 | -91.4% | 0.01% | -92.5% |
Q1 2018 | $51,909,000 | +68.7% | 1,484,373 | +67.4% | 0.17% | +73.0% |
Q4 2017 | $30,768,000 | +129.6% | 886,691 | +125.6% | 0.10% | +108.3% |
Q2 2017 | $13,401,000 | +414.8% | 393,097 | +396.3% | 0.05% | +433.3% |
Q3 2016 | $2,603,000 | -89.4% | 79,200 | -90.2% | 0.01% | -91.4% |
Q2 2016 | $24,493,000 | +124.7% | 811,285 | +109.6% | 0.10% | +101.9% |
Q1 2016 | $10,898,000 | +298.2% | 386,996 | +350.0% | 0.05% | +271.4% |
Q3 2015 | $2,737,000 | -78.7% | 86,005 | -57.3% | 0.01% | -76.7% |
Q2 2015 | $12,826,000 | +7.4% | 201,316 | +15.4% | 0.06% | +1.7% |
Q1 2015 | $11,941,000 | +187.0% | 174,501 | +199.6% | 0.06% | +210.5% |
Q3 2014 | $4,161,000 | -58.9% | 58,244 | -57.3% | 0.02% | -58.7% |
Q2 2014 | $10,135,000 | +46.2% | 136,387 | +16.8% | 0.05% | +21.1% |
Q4 2013 | $6,934,000 | -87.0% | 116,791 | -88.6% | 0.04% | -88.8% |
Q3 2013 | $53,270,000 | +38.3% | 1,025,814 | +26.0% | 0.34% | +26.4% |
Q2 2013 | $38,522,000 | – | 814,408 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |